Details for Patent: 8,859,551
✉ Email this page to a colleague
Which drugs does patent 8,859,551 protect, and when does it expire?
Patent 8,859,551 protects MIRVASO and is included in one NDA.
This patent has eighty-seven patent family members in twenty-five countries.
Summary for Patent: 8,859,551
| Title: | Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| Abstract: | In methods, compounds, and topical formulations for treatment of inflammatory skin disorders incorporating compounds represented by the formulas below: ##STR00001## wherein each of R.sub.1, R.sub.2, and R.sub.3 is independently hydrogen, hologen, alkyl, or alkoxy; each of R.sub.4 and R.sub.5 is independently hydrogen, alkyl, or alkoxy; and each of R.sub.6 and R.sub.7 is independently hydrogen, nitro, alkyl, or alkoxy; wherein each of A.sub.1, A.sub.3, and A.sub.4 is independently hydrogen or alkyl; and A.sub.2 is independently hydrogen or hydroxy; and wherein each of B.sub.1, B.sub.2, and B.sub.3 is independently hydrogen, hydroxy, or alkoxy; and each of B.sub.4 and B.sub.5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith. |
| Inventor(s): | DeJovin; Jack A. (New Brunswick, NJ), DeJovin; Isabelle Jean (New Brunswick, NJ) |
| Assignee: | Galderma Laboratories Inc. (Fort Worth, TX) |
| Application Number: | 13/775,784 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,859,551 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,859,551
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | MIRVASO | brimonidine tartrate | GEL;TOPICAL | 204708-001 | Aug 23, 2013 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,859,551
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1631293 | ⤷ Sign Up | CR 2014 00031 | Denmark | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | C300683 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | 1490049-2 | Sweden | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | C20140022 00150 | Estonia | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | 92462 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1631293 | ⤷ Sign Up | 191 5019-2014 | Slovakia | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
